Effectiveness and cost-effectiveness of 3-monthly versus 6-monthly monitoring of well-controlled type 2 diabetes patients: A pragmatic randomised controlled patient-preference equivalence trial in primary care (EFFIMODI study)

P.R. Wermeling, K.J. Gorter, R.K. Stellato, G.A. de Wit, J.W.J. Beulens, G.E.H.M. Rutten

Research output: Contribution to JournalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Effectiveness and cost-effectiveness of 3-monthly versus 6-monthly monitoring of well-controlled type 2 diabetes patients: A pragmatic randomised controlled patient-preference equivalence trial in primary care (EFFIMODI study)'. Together they form a unique fingerprint.

Medicine and Dentistry